#stem cells

Researchers at MUSC report that modified mesenchymal stem cells reversed new-onset type 1 diabetes in a mouse model by combining immune regulation with anti-inflammatory protection.

A stem cell-based muscle patch improved heart pumping in a small study of advanced heart failure, offering an early clinical signal for regenerative cardiac therapy.

China says it has become the first nation to send stem-cell-based human embryo models to space, aiming to study how microgravity and radiation affect early developmental processes.

Scientists at DKFZ and the HI-STEM Stem Cell Institute say they have identified a key mechanism behind treatment failure in acute myeloid leukemia, pointing to new paths for tackling resistance.

A new research clue suggests some patients with aplastic anemia may regain marrow function because protective blood stem cell clones help restore blood production.

Scientists working with stem-cell-derived heart tissue say microgravity can both accelerate heart-like decline and help grow more complex cardiac structures, potentially speeding studies of heart failure and repair.

A clinical trial targeting age-related vision disorders is renewing interest in partial reprogramming, a field that aims to rejuvenate damaged tissue without fully resetting cells to an embryonic state.

Researchers in Sweden report a more reliable way to make insulin-producing cells from human stem cells, with transplanted cells restoring blood sugar control in diabetic mice for months.

A study published in Cell Research reports a checkpoint that helps control the identity of multiple stem cell types across developmental stages, pointing to a potentially unifying principle in stem cell biology.

A Nature Medicine research highlight says a phase 1 study found placenta-derived stem cell therapy used during in utero myelomeningocele repair showed promise in an early safety assessment.

Researchers have demonstrated that transplanted neural stem cells can help preserve vision in models of retinal degeneration, offering a potential treatment pathway for conditions that currently have no cure.

Researchers are pairing lab-grown insulin cells with engineered immune bodyguards that prevent rejection — potentially eliminating the need for lifelong immunosuppression.